Follitropin delta clinical trials
Also written REKOVELLE and FE 999049.
How each study uses follitropin delta is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the follitropin delta studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 12 Dec 2016 · Rekovelle · EMEA/H/C/003994 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
23 studies that test it; most in 2018 (4)
| Year | Studies |
|---|---|
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 18 · Other 5
Ferring Pharmaceuticals (15) · Clinique Ovo (2) · Peter Kovacs MD (1) · Dr François Bissonnette (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · Fundación Santiago Dexeus Font (1) · Centre Hospitalier Intercommunal Creteil (1) · CRG UZ Brussel (1)
Often tested with
Tested in the same studies.
Follitropin alfa (2) · Menotropins (1) · Gonadotropin-releasing Hormone Analog (1) · Ovidrel (1) · Triptorelin (1)
Related medicines
As reviewed, each with the page that says it.
- A recombinant medicine of Follicle Stimulating Hormone source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test follitropin delta, phase 3 first.
- Jul 2027Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)Phase 3 · Fundación para la Investigación del Hospital Clínico de Valencia
- Dec 2026INtensity of OVarian Stimualtion and Euploid EmbryosPhase 4 · Fundación Santiago Dexeus Font
Studies
Open first, then newest update. How each study uses follitropin delta is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 23
- Ovulation Trigger Strategies in Low Ovarian Reserve (TRIGGERBEST)RecruitingPhase 3Fundación para la Investigación del Hospital Clínico de ValenciaNCT07816562Written as Follitropin delta
- INtensity of OVarian Stimualtion and Euploid EmbryosRecruitingPhase 4Fundación Santiago Dexeus FontNCT06154083Written as Follitropin-delta (Rekovelle) 20 mcg/day from D1
- Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)RecruitingPhase 2Centre Hospitalier Intercommunal CreteilNCT07153367Written as REKOVELLE (Follitropin Delta)
- Menopur And Rekovelle Combination Study Version 2.0RecruitingPhase 2Clinique OvoNCT06997900Written as Combination therapy : Follitropin delta and HP-hMG
- Luteal Phase Ovarian Stimulation With Follitropin Delta and DydrogesteroneRecruitingNot applicableCRG UZ BrusselNCT05521828Written as Follitropin delta (Rekovelle)
- A Trial to Compare Efficacy and Safety of Follitropin Delta Versus Placebo (Inactive Treatment) in the Treatment of Men With Idiopathic Infertility (Unexplained Reduction of Semen Quality) (ADAM)TerminatedPhase 2Ferring PharmaceuticalsNCT05403476Written as FE 999049
- A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in ChinaCompletedPhase 3Ferring PharmaceuticalsNCT06173869Written as FE 999049
- A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian StimulationCompletedPhase 3Ferring PharmaceuticalsNCT05263388Written as REKOVELLE (Follitropin Delta)
- Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Indian WomenCompletedPhase 3Ferring PharmaceuticalsNCT04773353Written as Follitropin Delta (FE 999049)
- Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor RespondersCompletedNot applicablePeter Kovacs MDNCT05103228Written as Follitropin delta
- Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)CompletedPhase 3Ferring PharmaceuticalsNCT03809429Written as FE 999049 + GnRH agonist (GONAPEPTYL)
- Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-2)CompletedPhase 3Ferring PharmaceuticalsNCT03738618Written as Follitropin delta
- Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)CompletedPhase 3Ferring PharmaceuticalsNCT03740737Written as Follitropin delta
- Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2CompletedPhase 3Ferring PharmaceuticalsNCT01956123Written as Follitropin Delta (FE 999049)
- A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.CompletedPhase 2Ferring PharmaceuticalsNCT03564509Written as FE 999302 (1 μg) and follitropin delta
- Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Pan-Asian WomenCompletedPhase 3Ferring PharmaceuticalsNCT03296527Written as Follitropin delta
- Efficacy and Safety of FE 999049 in Controlled Ovarian Stimulation in Japanese WomenCompletedPhase 3Ferring PharmaceuticalsNCT03228680Written as Follitropin delta
- Rekovelle PK Trial in Chinese WomenCompletedPhase 1Ferring PharmaceuticalsNCT04150861Written as Follitropin Delta
- Personalized Insemination Treatment StudyCompletedPhase 2Clinique OvoNCT03830723Written as Follitropin delta
- Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 1CompletedPhase 3Ferring PharmaceuticalsNCT01956110Written as Follitropin Delta (FE 999049)
See all 23 studies that test follitropin delta →
Given beside what is tested · 2 — follitropin delta is usual care or a partner of the new treatment
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta at Different Time Intervals During Controlled Ovarian Stimulation.TerminatedPhase 1Ferring PharmaceuticalsNCT06511791Written as Follitropin delta
- An Exploratory Study to Investigate the Effect of FE 999302 When Given Together With Follitropin Delta During Controlled Ovarian StimulationTerminatedPhase 1Ferring PharmaceuticalsNCT06466486Written as Follitropin delta
Codes
What other systems call follitropin delta · ClinicalTrials.gg INT000704
- UNII (FDA) 2M2GGL7HUPFOLLITROPIN DELTAOne source FDA
- NCI Thesaurus C171909Follitropin DeltaOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 2M2GGL7HUP | FOLLITROPIN DELTA | One source FDA |
| NCI Thesaurus | C171909 | Follitropin Delta | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.